Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
ViraMatix

ViraMatix

Involved in the development of peptide based anti-viral therapeutics


Presenter:

Robert Hercus, Director

Xerion Healthcare

Xerion Healthcare

Developing nanoparticles used to improve treatment of cancer


Presenter:

Gareth Wakefield, CTO